Noah Goodman

Chief Business Officer, Kymera Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$2.2M

Companies

Latest trade

Jul 1, 2026

Companies

Kymera Therapeutics, Inc.Chief Business Officer −$2.2M

Trades

KYMR Sold 3,389 shares at $114.29 · planned $0.4M Jul 1

KYMR Sold 5,000 shares at $114.00 · planned $0.6M Jun 25

KYMR Sold 2,500 shares at $99.00 · planned $0.2M Jun 22

KYMR Sold 1,347 shares at $90.00 · planned $0.1M Apr 14

KYMR Sold 2,000 shares at $87.35 · planned $0.2M Apr 10

KYMR Sold 8,264 shares at $87.50 · planned $0.7M Apr 9

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.